Jalil Hosseini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jalil Hosseini has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Shahrzad Nematollahi
Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
9 shared publicationsFereshteh Aliakbari
Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7 shared publicationsMohammad Ali Hosseini
Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
6 shared publicationsEhsan Shojaeefar
Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publicationsFereshte Aliakbari
Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publicationsAli Tayyebi Azar
Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26  (1)
Persian version of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms caregiver module: translation, validation and cultural adaptation
Currently, the International Consultation on Incontinence Questionnaire–Pediatric Lower Urinary Tract Symptoms (ICIQ-CLUTS), a well-established tool
- 24 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26  (1)
Open AccessPersian version of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms caregiver module: translation, validation and cultural adaptation
Currently, the International Consultation on Incontinence Questionnaire–Pediatric Lower Urinary Tract Symptoms (ICIQ-CLUTS), a well-established tool
- 1 November 2024
- Vol. 21  (6) , 404-409
Efficacy and Complications of Mitrofanoff Continent Urinary Diversion in Adults with Complex Urethral Strictures: A Single-Center Experience
Purpose: The management of complicated and irreparable urethral strictures can be challenging, and continent urinary diversion has emerged as a viable option. This study aims to investigate the complications associated with continent urinary diversion using the Mitrofanoff principle in patients with complex urethral strictures that cannot be corrected through urethroplasty surgery. Materials and Methods: A total of 22 patients were included in this study, who underwent continent urinary diversion surgery using the Mitrofanoff technique. The patients were monitored for post-surgical complications over an average follow-up period of 28.36 +/- 14.26 months. Surgical failure was defined as the inability to completely and regularly empty urine from the new urinary tract. Results: Half of the patients experienced surgical complications, with only one case resulting in surgery failure. The most common complication observed was stoma stenosis. Two patients reported slight urinary leakage from the stoma site. Notably, all patients except one, regained control over their urine after the procedure. Early therapeutic interventions were classified according to the Clavien-Dindo grading system, showed that none of the patients experienced severe complications (grade 4 or 5). Conclusion: The study examines the outcomes of continent urinary diversion using the Mitrofanoff technique in adults with complex urethral strictures, providing realistic expectations of complications. Overall, the study shows that this approach is a viable option with a high success rate and manageable complication for individuals with complex urethral strictures that cannot be corrected through urethroplasty surgery.
- 1 November 2024
- Vol. 21  (6) , 404-409
Efficacy and Complications of Mitrofanoff Continent Urinary Diversion in Adults with Complex Urethral Strictures: A Single-Center Experience
Purpose: The management of complicated and irreparable urethral strictures can be challenging, and continent urinary diversion has emerged as a viable option. This study aims to investigate the complications associated with continent urinary diversion using the Mitrofanoff principle in patients with complex urethral strictures that cannot be corrected through urethroplasty surgery. Materials and Methods: A total of 22 patients were included in this study, who underwent continent urinary diversion surgery using the Mitrofanoff technique. The patients were monitored for post-surgical complications over an average follow-up period of 28.36 +/- 14.26 months. Surgical failure was defined as the inability to completely and regularly empty urine from the new urinary tract. Results: Half of the patients experienced surgical complications, with only one case resulting in surgery failure. The most common complication observed was stoma stenosis. Two patients reported slight urinary leakage from the stoma site. Notably, all patients except one, regained control over their urine after the procedure. Early therapeutic interventions were classified according to the Clavien-Dindo grading system, showed that none of the patients experienced severe complications (grade 4 or 5). Conclusion: The study examines the outcomes of continent urinary diversion using the Mitrofanoff technique in adults with complex urethral strictures, providing realistic expectations of complications. Overall, the study shows that this approach is a viable option with a high success rate and manageable complication for individuals with complex urethral strictures that cannot be corrected through urethroplasty surgery.
- Open Access
- 28 April 2024
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 70  (4) , 242-247
Correlation of IDH1 gene expression error in breast tumor biopsy in patients with invasive ductal carcinoma
One of the most important cancers in terms of worldwide prevalence is breast tumors, which have been less investigated in correlation with the enzyme Isocitrate Dehydrogenase 1 (IDH1) gene. The aim of this study was that expression of this gene could have significant effects on the progression of metastasis and invasive disease in breast cancer patients. We used the molecular method of RT-PCR with SYBR-Green to analyze breast tumor tissue from patients with metastasis and non-metastasis, the latter confirmed by the pathology department of Shohada-e Tajrish Hospital (serving as a control group). Also, patients population and its relationship with the degree of tumor in the IDH1 gene was investigated. The IDH1 gene has shown high expression in patients with metastatic breast cancer rather than in patients with non-metastatic breast cancer. The metastatic samples were compared with non-metastatic samples for IDH1 mRNA expression. In this research work, 72.5% (29 samples) were up-regulated in comparison to 27.5% of samples (11 samples) that did not exhibit high expression (P=0.000). This study examined the IDH1 gene expression, suggesting that changes in this genes expression could impact the prognosis of breast cancer. However, further research is needed to draw definitive conclusions.
- 28 April 2024
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 70  (4) , 242-247
Open AccessCorrelation of IDH1 gene expression error in breast tumor biopsy in patients with invasive ductal carcinoma
One of the most important cancers in terms of worldwide prevalence is breast tumors, which have been less investigated in correlation with the enzyme Isocitrate Dehydrogenase 1 (IDH1) gene. The aim of this study was that expression of this gene could have significant effects on the progression of metastasis and invasive disease in breast cancer patients. We used the molecular method of RT-PCR with SYBR-Green to analyze breast tumor tissue from patients with metastasis and non-metastasis, the latter confirmed by the pathology department of Shohada-e Tajrish Hospital (serving as a control group). Also, patients population and its relationship with the degree of tumor in the IDH1 gene was investigated. The IDH1 gene has shown high expression in patients with metastatic breast cancer rather than in patients with non-metastatic breast cancer. The metastatic samples were compared with non-metastatic samples for IDH1 mRNA expression. In this research work, 72.5% (29 samples) were up-regulated in comparison to 27.5% of samples (11 samples) that did not exhibit high expression (P=0.000). This study examined the IDH1 gene expression, suggesting that changes in this genes expression could impact the prognosis of breast cancer. However, further research is needed to draw definitive conclusions.
- Open Access
- 13 June 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24  (1) , 1-7
Elevated angiopoietin-like protein 3 serum levels in diabetic nephropathy patients and its association with renal function and lipid profile
Background: Type 2 diabetes mellitus (T2DM) is a highly prevalent disease that has life-threatening consequences like micro and macrovascular complication. Diabetic nephropathy (DN) is one of the common consequences of T2DM which is related to secretory factors like hepatokines. Angiopoietin-Like Protein 3 (ANGPTL3) is a hepatokine that is perturbated in cardiometabolic diseases and experimental studies showed its effect on renal functions and lipid metabolism. For the first time, ANGPTL3 was measured in patients with T2DM and DN in the present study. Methods: Serum levels of ANGPTL3, IL-6, and TNF-α were measured in 60 healthy control, 60 T2DM patients, and 61 DN patients. Results: Serum levels of ANGPTL3 increased in T2DM (252.39 ± 66.01) and DN (284.59 ± 69.27) patients compared to controls (160.22 ± 48.96), and DN patients compared with T2DM patients. Urinary albumin excretion (UAE) was higher in the DN group compared to T2DM and control groups. Moreover, serum levels of IL-6 and TNF-α were elevated in both patient groups compared to controls. Moreover, ANGPTL3 represented a positive correlation with triglycerides, creatinine, and UAE in patients with both T2DM and DN groups and showed an inverse correlation with eGFR in patients with DN. Moreover, this hepatokine had a good potential to differentiate patients from controls, especially, DN patients. Conclusions: these findings provide invivo evidence for the relation of ANGPTL3 with renal dysfunction and hypertriglyceridemia in patients with DN which is in line with experimental findings and suggested a potential role for this hepatokine in DN pathogenesis.
- 13 June 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24  (1) , 1-7
Open AccessElevated angiopoietin-like protein 3 serum levels in diabetic nephropathy patients and its association with renal function and lipid profile
Background: Type 2 diabetes mellitus (T2DM) is a highly prevalent disease that has life-threatening consequences like micro and macrovascular complication. Diabetic nephropathy (DN) is one of the common consequences of T2DM which is related to secretory factors like hepatokines. Angiopoietin-Like Protein 3 (ANGPTL3) is a hepatokine that is perturbated in cardiometabolic diseases and experimental studies showed its effect on renal functions and lipid metabolism. For the first time, ANGPTL3 was measured in patients with T2DM and DN in the present study. Methods: Serum levels of ANGPTL3, IL-6, and TNF-α were measured in 60 healthy control, 60 T2DM patients, and 61 DN patients. Results: Serum levels of ANGPTL3 increased in T2DM (252.39 ± 66.01) and DN (284.59 ± 69.27) patients compared to controls (160.22 ± 48.96), and DN patients compared with T2DM patients. Urinary albumin excretion (UAE) was higher in the DN group compared to T2DM and control groups. Moreover, serum levels of IL-6 and TNF-α were elevated in both patient groups compared to controls. Moreover, ANGPTL3 represented a positive correlation with triglycerides, creatinine, and UAE in patients with both T2DM and DN groups and showed an inverse correlation with eGFR in patients with DN. Moreover, this hepatokine had a good potential to differentiate patients from controls, especially, DN patients. Conclusions: these findings provide invivo evidence for the relation of ANGPTL3 with renal dysfunction and hypertriglyceridemia in patients with DN which is in line with experimental findings and suggested a potential role for this hepatokine in DN pathogenesis.
- Open Access
- 7 January 2023
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 15  (1)
The Prevalence of Erectile Dysfunction Among Adult Men: The Results of a National Survey on Male Morbidities
Background: Men’s sexual health is one of the main aspects of their lives. Male sexual dysfunction (SD) includes a wide range of sexual impairments and is not limited to premature ejaculation (PE) and erectile dysfunction (ED). ED can be a life-changing issue that might be mixed up with male sexual impotence characterized by PE and ED. Objectives: The objectives of this study were to estimate the prevalence of sexual dysfunction and its associated factors among the Iranian male population. Methods: This is a cross-sectional study for which data was collected from a nationwide reproductive morbidities project among males in Iran. To do so, 2296 men aged 25 - 60 years were selected from four provinces by cluster sampling. Statistical analysis was done in SPSS (18.0.0) Results: The prevalence of severe/medium SD and severe SD were 66.9% and 18.1%, respectively. The prevalence of low sexual satisfaction, low sexual desire, and dissatisfaction with the length of intercourse before orgasm were 9.5%, 9%, and 12%. Conclusions: Sexual dysfunction is highly likely prevalent among less educated, unemployed men with a history of chronic diseases. Various educational programs to raise awareness are thoroughly recommended.
- 7 January 2023
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 15  (1)
Open AccessThe Prevalence of Erectile Dysfunction Among Adult Men: The Results of a National Survey on Male Morbidities
Background: Men’s sexual health is one of the main aspects of their lives. Male sexual dysfunction (SD) includes a wide range of sexual impairments and is not limited to premature ejaculation (PE) and erectile dysfunction (ED). ED can be a life-changing issue that might be mixed up with male sexual impotence characterized by PE and ED. Objectives: The objectives of this study were to estimate the prevalence of sexual dysfunction and its associated factors among the Iranian male population. Methods: This is a cross-sectional study for which data was collected from a nationwide reproductive morbidities project among males in Iran. To do so, 2296 men aged 25 - 60 years were selected from four provinces by cluster sampling. Statistical analysis was done in SPSS (18.0.0) Results: The prevalence of severe/medium SD and severe SD were 66.9% and 18.1%, respectively. The prevalence of low sexual satisfaction, low sexual desire, and dissatisfaction with the length of intercourse before orgasm were 9.5%, 9%, and 12%. Conclusions: Sexual dysfunction is highly likely prevalent among less educated, unemployed men with a history of chronic diseases. Various educational programs to raise awareness are thoroughly recommended.
- Open Access
- 28 August 2022
- Vol. 24  (8) , 442-448
The Effect of miR-106b-5p Expression in The Production of iPS-Like Cells from Mice SSCs during The Formation of Teratoma and The Three Embryonic Layers
Objective: According to the mounting data, microRNAs (miRNAs) may play a key role in reprogramming. miR-106b is considered as an enhancer in reprogramming efficiency. Based on induced pluripotent stem cells (iPSCs), cell treatments have a huge amount of potential. One of the main concerns about using iPSCs in therapeutic settings is the possibility of tumor formation. It is hypothesized that a procedure that can reprogram cells with less genetic manipulation reduces the possibility of tumorigenicity.Materials and Methods: In this experimental study, miR-106b-5p transduced by pLV-miRNA vector into mice isolated spermatogonial stem cells (SSCs) to achieve iPS-like cells. Then the transduced cells were cultured in specific conditions to study the formation of three germ layers. The tumorigenicity of these iPS-like cells was investigated by transplantation into male BALB/C mice.Results: We show that SSCs can be successfully reprogrammed into induced iPS-like cells by pLV-miRNA vector to transduce the hsa-mir-106b-5p into SSCs and generating osteogenic, neural and hepatoblast lineage cells in vitro as a result of pluripotency. Although these iPS-like cells are pluripotent, they cannot form palpable tumors in vivo.Conclusion: These results demonstrate that infection of hsa-mir-106b-5p into SSCs can reprogram them into iPSCs and advanced germ cell lineages without tumorigenicity. Also, a novel approach for studying the generation of iPSCs and the application of iPS or iPS-like cells in regenerative medicine is presented.
- 28 August 2022
- Vol. 24  (8) , 442-448
Open AccessThe Effect of miR-106b-5p Expression in The Production of iPS-Like Cells from Mice SSCs during The Formation of Teratoma and The Three Embryonic Layers
Objective: According to the mounting data, microRNAs (miRNAs) may play a key role in reprogramming. miR-106b is considered as an enhancer in reprogramming efficiency. Based on induced pluripotent stem cells (iPSCs), cell treatments have a huge amount of potential. One of the main concerns about using iPSCs in therapeutic settings is the possibility of tumor formation. It is hypothesized that a procedure that can reprogram cells with less genetic manipulation reduces the possibility of tumorigenicity.Materials and Methods: In this experimental study, miR-106b-5p transduced by pLV-miRNA vector into mice isolated spermatogonial stem cells (SSCs) to achieve iPS-like cells. Then the transduced cells were cultured in specific conditions to study the formation of three germ layers. The tumorigenicity of these iPS-like cells was investigated by transplantation into male BALB/C mice.Results: We show that SSCs can be successfully reprogrammed into induced iPS-like cells by pLV-miRNA vector to transduce the hsa-mir-106b-5p into SSCs and generating osteogenic, neural and hepatoblast lineage cells in vitro as a result of pluripotency. Although these iPS-like cells are pluripotent, they cannot form palpable tumors in vivo.Conclusion: These results demonstrate that infection of hsa-mir-106b-5p into SSCs can reprogram them into iPSCs and advanced germ cell lineages without tumorigenicity. Also, a novel approach for studying the generation of iPSCs and the application of iPS or iPS-like cells in regenerative medicine is presented.
- Open Access
- 5 July 2022
- Published by CMV Verlag in Iranian Biomedical Journal
- Vol. 26  (4) , 291-300
MiR-106b-5p Regulates the Reprogramming of Spermatogonial Stem Cells into iPSC (Induced Pluripotent Stem Cell)-Like Cells
Background: Recent years have brought notable progress in raising the efficiency of the reprogramming technique so that approaches have evolved from known transgenic factors to only a few miRNAs. Nevertheless, there is a poor understanding of both the key factors and biological networks underlying this reprogramming. The present study aimed to investigate ...
- 5 July 2022
- Published by CMV Verlag in Iranian Biomedical Journal
- Vol. 26  (4) , 291-300
Open AccessMiR-106b-5p Regulates the Reprogramming of Spermatogonial Stem Cells into iPSC (Induced Pluripotent Stem Cell)-Like Cells
Background: Recent years have brought notable progress in raising the efficiency of the reprogramming technique so that approaches have evolved from known transgenic factors to only a few miRNAs. Nevertheless, there is a poor understanding of both the key factors and biological networks underlying this reprogramming. The present study aimed to investigate ...
- 7 August 2021
- Vol. 5  (1) , e32
Predictors of Testis Cancer Mortality in Iran
- 25 July 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48  (7) , 5443-5450
Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy
Introduction Adipokines play an important role in the development of type 2 diabetes mellitus (T2DM) and its complications like nephropathy. Asprosin is a newly discovered adipokine involved in glucose metabolism and inflammation process. The present study aimed to evaluate asprosin levels in patients with T2DM and T2DM + nephropathy (NP) compared to control subjects as well as investigating its relationship with insulin resistance, inflammation, and renal function markers. Methods Serum levels of asprosin, adiponectin, IL-6, and TNF-α were measured in 55 control subjects, 54 T2DM, and 55 T2DM + NP patients using ELISA kits. Results Asprosin was found to be higher in the T2DM (6.73 ± 1.67) and T2DM + NP (7.11 ± 1.54) patients compared to the controls (4.81 ± 1.09) (p < 0.001), while adiponectin indicated a lower concentration in both patient groups compared to the control group. Moreover, IL-6 and TNF-α indicated higher levels in the two patients group compared to the control group. Asprosin was observed to have a positive correlation with HbA1c, FBG, TC, LDL-C, IL-6, and TNF-α in the T2DM group. In the patients with T2DM + NP, asprosin was found to be positively correlated with BMI, HbA1c, insulin, HOMA-IR, Cr, UAE, IL-6, and TNF-α, and it was inversely correlated with eGFR. Conclusion Higher concentrations of asprosin in the T2DM and T2DM + NP groups and its relationship with glucose and lipid metabolism and markers of renal function and inflammation suggested a possible role for this adipokine in the pathogenesis of both T2DM and nephropathy.
- 25 July 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48  (7) , 5443-5450
Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy
Introduction Adipokines play an important role in the development of type 2 diabetes mellitus (T2DM) and its complications like nephropathy. Asprosin is a newly discovered adipokine involved in glucose metabolism and inflammation process. The present study aimed to evaluate asprosin levels in patients with T2DM and T2DM + nephropathy (NP) compared to control subjects as well as investigating its relationship with insulin resistance, inflammation, and renal function markers. Methods Serum levels of asprosin, adiponectin, IL-6, and TNF-α were measured in 55 control subjects, 54 T2DM, and 55 T2DM + NP patients using ELISA kits. Results Asprosin was found to be higher in the T2DM (6.73 ± 1.67) and T2DM + NP (7.11 ± 1.54) patients compared to the controls (4.81 ± 1.09) (p < 0.001), while adiponectin indicated a lower concentration in both patient groups compared to the control group. Moreover, IL-6 and TNF-α indicated higher levels in the two patients group compared to the control group. Asprosin was observed to have a positive correlation with HbA1c, FBG, TC, LDL-C, IL-6, and TNF-α in the T2DM group. In the patients with T2DM + NP, asprosin was found to be positively correlated with BMI, HbA1c, insulin, HOMA-IR, Cr, UAE, IL-6, and TNF-α, and it was inversely correlated with eGFR. Conclusion Higher concentrations of asprosin in the T2DM and T2DM + NP groups and its relationship with glucose and lipid metabolism and markers of renal function and inflammation suggested a possible role for this adipokine in the pathogenesis of both T2DM and nephropathy.
- 28 June 2021
- Vol. 5  (1) , e30
Incidence of Penile Fracture in Iran, a Cross-Sectional Study